BIO Digital Day #2: Dr. Fauci!

June 9, 2020
What's Dr. Fauci's worst nightmare? When will we have a vaccine? What does he really think about Brad Pitt playing him on SNL? We got these answers and more today. Here’s a quick recap of BIO Digital Day 2. Like what you see? Click here to opt in to continue receiving…
BIO

What's Dr. Fauci's worst nightmare? When will we have a vaccine? What does he really think about Brad Pitt playing him on SNL? We got these answers and more today.

Here’s a quick recap of BIO Digital Day 2. 

Like what you see? Click here to opt in to continue receiving Good Day BIO after the event.

Dr. Fauci!
DrFauci-GoodDayBIO.png
 
Paragraph (sm) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel facilisis sample link.
 

Speaking during a one-on-one chat with BIO President and CEO Dr. Michelle McMurry-Heath, Dr. Anthony Fauci, Director of the NIH National Institute of Allergy and Infectious Diseases, drew viewers from around the globe, from California to Kansas, Italy to Vietnam.

The big news: Dr. Fauci expects there will be "more than one winner in the vaccine field" but warns that COVID-19 meets the criteria for "his worst nightmare." 

He said he was surprised at "how rapidly it just took over the planet."

But hope is on the horizon thanks to biopharmaceutical innovators. "I’m very heartened by the fact that the industry has stepped to the plate—very much differently than what we saw with SARS," Dr. Fauci noted.

And about that SNL skit? 

"If you start taking that kind of stuff seriously...you're really in trouble," he laughed.

"I'm not as good looking as Brad Pitt and no matter what you do to me, I'm never going to be as good looking as Brad Pitt."

(Well, we're sure quite a few people in the biotech community might disagree!)

Read the whole thing on the BIO Digital Live Blog

Watch what he had to say about the biotech industry.

And stay tuned...because we'll have more on what he said about health disparities in the United States tomorrow.

 
 
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
Twitter
 
LinkedIn
 
Facebook
 
What We Learned on Day 2

1. In the vaccine race, there won’t be just one winner. “The idea isn’t to pick a winner; it’s to have multiple shots on goal,” said Dr. Mark McClellan, Director of the Duke Margolis Center for Health Policy.

“Everyone will need to work together,” added Dr. Peter Marks, Director of FDA's Center for Biologics Evaluation and Research. “This is really a global issue where we're all connected.” 

Dr. Fauci likewise said he expects “more than one winner” in both vaccines and therapeutics.

2. The pandemic has shown just how interconnected global biotech R&D has become. During the international plenary, Amgen's Christophe Bourdon pointed out the importance of investing in science before a second outbreak occurs: “We know it’s going to come, and we cannot be taken by surprise.” 

“Science is a global enterprise and we need to bring together the best and brightest minds, wherever they are, across borders and across sectors,” echoed the National Academy of Medicine’s Dr. Margaret Hamburg during the vaccine plenary.

3. But we have to think about the vaccine supply chain, too. During the third and final part of the vaccine plenary, panelists said scaling up manufacturing is equally important as developing the science. In fact, Moderna is already investing in manufacturing space, equipment, and raw materials.

If investing in manufacturing now before we have an approved vaccine saves even two weeks in delivering an eventual vaccine, we’ll save even more in terms of human lives and the economy, added CEPI’s Dr. Richard Hatchett.

4. Everything we do now will help us prepare for the next pandemic. "Developing a safe and effective vaccine in a global pandemic is a daunting challenge," said John Markels, President, Global Vaccines at Merck, while discussing his company’s experience with Ebola. "We need to be better prepared in the future, and I do think all the things we're doing now will put us in a better position.”

Want more?

  • Head to the BIO Digital Liveblog, where we’ve got a team of writers bringing you session highlights, news, and context, live and in real time as the sessions are happening.
  • Join the conversation at @IAmBiotech and @BIOConvention. #BIODigital
  • Did we give you FOMO? We have a limited number of sessions available on-demand on our website at www.bio.org/bestofbio.
Sponsored Content from Cytiva
cytiva-gooddaybio-ad-3.png
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
 

The increasing scrutiny over the cost of biopharmaceuticals, combined with the need to bring life-saving therapies to emerging regions, requires businesses to balance social and financial needs, while driving patient access. Standardization is one tool that is essential to building a successful global business strategy.

Learn why customization is not efficient

 
The Last Word
DaveRicks_GoodDayBIO.png
 
Paragraph (sm) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel facilisis sample link.
 
We've got a sneak peek of this afternoon's fireside chat with Dave Ricks, Chairman and CEO of Eli Lilly and Company, where he offers inspirational words to the industry: "If I had one wish for my company, BIO, and the industry, it's that we can all remember what it feels like right now to work in this industry that's essential for the world."

You can watch the session today at 7:30 PM ET/4:30 PM PT or on-demand after in the BIO Digital Hubb.

 
 
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
Twitter
 
LinkedIn
 
Facebook